421 related articles for article (PubMed ID: 20025970)
1. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
2. Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice.
Doehner J; Madhusudan A; Konietzko U; Fritschy JM; Knuesel I
J Alzheimers Dis; 2010; 19(4):1339-57. PubMed ID: 20061602
[TBL] [Abstract][Full Text] [Related]
3. Age-related accumulation of Reelin in amyloid-like deposits.
Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
[TBL] [Abstract][Full Text] [Related]
4. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
[TBL] [Abstract][Full Text] [Related]
5. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging.
Madhusudan A; Sidler C; Knuesel I
Eur J Neurosci; 2009 Sep; 30(6):1064-76. PubMed ID: 19735296
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
9. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
10. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
[TBL] [Abstract][Full Text] [Related]
11. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
12. The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.
Cuchillo-Ibañez I; Mata-Balaguer T; Balmaceda V; Arranz JJ; Nimpf J; Sáez-Valero J
Sci Rep; 2016 Aug; 6():31646. PubMed ID: 27531658
[TBL] [Abstract][Full Text] [Related]
13. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
Mata-Balaguer T; Cuchillo-Ibañez I; Calero M; Ferrer I; Sáez-Valero J
FASEB J; 2018 Jul; 32(7):3536-3546. PubMed ID: 29442527
[TBL] [Abstract][Full Text] [Related]
14. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
15. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
[TBL] [Abstract][Full Text] [Related]
16. Prion protein (PrPc) promotes beta-amyloid plaque formation.
Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
[TBL] [Abstract][Full Text] [Related]
17. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
Tan J; Town T; Crawford F; Mori T; DelleDonne A; Crescentini R; Obregon D; Flavell RA; Mullan MJ
Nat Neurosci; 2002 Dec; 5(12):1288-93. PubMed ID: 12402041
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
[TBL] [Abstract][Full Text] [Related]
19. Intracellular amyloid-beta in Alzheimer's disease.
LaFerla FM; Green KN; Oddo S
Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
[TBL] [Abstract][Full Text] [Related]
20. Reelin and apoE actions on signal transduction, synaptic function and memory formation.
Rogers JT; Weeber EJ
Neuron Glia Biol; 2008 Aug; 4(3):259-70. PubMed ID: 19674510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]